Screening assay for anti-HIV drugs

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 72, 435 721, G01N 3353, G01N 33567

Patent

active

057211043

ABSTRACT:
The essential role of the Vpr protein of HIV in the progression of HIV infection is disclosed. Recognition of this role permits assay for potential drug candidates by virtue of their ability to interfere with the interaction of Vpr with its intracellular targets. Thus, cells that are modified to contain an expression system for the production of Vpr are cultured in the presence and absence of the drug candidate and the growth rates compared. The ability of a candidate to enhance the growth of a culture producing Vpr indicates its potential as an anti-AIDS therapeutic.

REFERENCES:
Balotta, C., Antisense Phosphorothioate Oligodeoxynucleotides Targeted to the vpr Gene Inhibit Human Immunodeficienc Virus Type 1 Replication in Primary Human Macrophages, J. Virol (1993) 67:4409.
Cohen, E.A. et al. Identification of HIV-1 vpr Product and Function, J AIDS (1990) 3:11-18.
Cohen, E.A. et al. Human Immunodeficiency Virus vpr Product Is a Virion-Associated Regulatory Protein, J Virol (1990) 64:3097-3099.
Gras-Masse, H. et al. A Synthetic Protein Corresponding to the Entire vpr Gene Product from the Human Immunodeficiency virus HIV-1 is Recognized by Antibodies from HIV-Infected Patients, Int J Pept Prot Res (1990) 36:219.
Hattori, N. et al. The Human Innumodeficiency Virus Type 2 vpr Gene is Essential for Productive Infection of Human Macrophages, Proc Natl Acad Sci USA (1990) 87:8080-8084.
Heinzinger, N.K. et al. The Vpr Protein of Human Immunodeficiency Virus Type 1 Influences Nuclear Localizatioin of Viral Nucleic Acids in Nondividing Host Cells, Proc Natl Acad Sci USA (1994) 91:7311-7315.
Lang, S.M. et al. Importance of vpr for Infection of Rhesus Monkeys with Simian Immunodeficiency Virus, J Virol (1993) 67:902-912.
Lavallee, C. et al. Requirements of the Pr55.sup.gag Precursor for Incorporation of the Vpr Product into Human Immunodeficiency Virus Type 1 Viral Particles, J Virol (1994) 68:1926.
Levy, D.N. et al. Induction of Cell Differentiation by Human Immunodeficiency Virus 1 vpr, Cell (1993) 72:541.
Ogawa, K. et al. Open Reading Frame J Virol (1990) 63:4110-4114.
Paxton, W. et al. Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Virions: Requirement for the p6 Region of gag and Mutational Analysis, J Virol (1993) 67:7229-7237.
Pianelles et al., Manuscript: "Vpr-Induced Cell Cycle Arrest is Conserved Among Primate Lentiviruses", University of Alabama at Birmingham, Division of Hematology and Oncology (date not available).
Reiss, P. et al. Antibody Response to Viral Proteins U (vpu) and R (vpr) in HIV-1-Infected Individuals, J AIDS (1990) 3:115.
Tristem, M. et al. Evolution of the Primate Lentiviruses: Evidence form vpx and vpr, EMBO J (1992) 11:3405.
Yu, et al. Open Reading Frame vpr of Simian Immunodeficiency Virus Encodes a Virion-Associated Protein, J Virol (1990) 64:5688.
Yuan et al., AIDS Research and Human Retroviruses, vol. 6, No. 11, issued 1990, "Human Immunodeficiency Virus vpr Gene Encodes a Virion-Associated Protein", pp. 1265-1271.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Screening assay for anti-HIV drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening assay for anti-HIV drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assay for anti-HIV drugs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1874402

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.